What the Kratom and 7-OH Surge Means for Peer Recovery Support

Addiction treatment centers across the country are reporting a sharp rise in patients seeking help for dependence on kratom and concentrated 7-hydroxymitragynine (7-OH) products, according to reporting this month from STAT News. At Boulder Care, a telehealth addiction clinic, kratom-related cases grew from about 3% of new admissions in September 2025 to 14% by August 2026. Recovery Centers of America's Massachusetts facility said it went from treating roughly one kratom-related patient a week to 10 to 20 a week over the same period, and federal poison-control data show calls related to kratom rising from 258 to 3,434 over the past decade, with a sharp increase in 2025.

Clinicians told STAT that concentrated 7-OH products — often marketed as energy or wellness supplements and sold with little regulation — act more directly on the body's opioid receptors than traditional kratom leaf, producing withdrawal some described as comparable in severity to opioid withdrawal. Providers are increasingly using medications such as buprenorphine to manage it. The U.S. Food and Drug Administration has flagged 7-OH as an emerging opioid threat, the Drug Enforcement Administration has proposed restricting concentrated 7-OH products, and a growing number of states have passed their own restrictions.

For Davis Direction Foundation, this story is a reminder that the substances bringing people into treatment do not stay fixed. Many people still encounter kratom and 7-OH products as loosely regulated "wellness" or energy supplements sold at gas stations and smoke shops, not as substances capable of producing opioid-like withdrawal. That gap between how a product is marketed and how it actually behaves in the body is exactly the kind of thing peer recovery support exists to help people navigate.

At The Zone, DDF's peer recovery support organization in Marietta, certified peer recovery coaches meet people wherever they are in their relationship with substances — not just alcohol or opioids in the forms most people expect, but whatever has actually brought someone through the door. A rise in kratom and 7-OH dependence nationally is a sign that the landscape of substance use keeps shifting, often faster than public awareness or regulation can keep pace, and that recovery support has to keep learning alongside it.

It's also a reminder of something DDF treats as central to its work: withdrawal and dependence are physiological realities, not moral failings, whatever the substance and however it was obtained. Clinicians quoted in the reporting described treating 7-OH withdrawal with the same seriousness as opioid withdrawal, using established medications to manage it safely. That evidence-based, non-judgmental posture — treat the withdrawal, support the person, skip the stigma — is the same posture peer recovery coaches aim to bring to every conversation at The Zone, regardless of what substance someone is coming off of.

There's a community education piece here too. Products marketed as supplements can carry a real risk of dependence, and people using them may not think of themselves as candidates for addiction treatment or recovery support until withdrawal hits. Part of DDF's role, alongside direct peer support, is helping the community understand that recovery resources are for anyone navigating a difficult relationship with a substance — however that substance is labeled on the package.